Effect of low-normal vs high-normal oxygenation targets on organ dysfunction in critically ill patients: a randomized clinical trial H Gelissen, HJ de Grooth, Y Smulders, EJ Wils, W de Ruijter, R Vink, ... Jama 326 (10), 940-948, 2021 | 87 | 2021 |
Renal resistive index as an early predictor and discriminator of acute kidney injury in critically ill patients; A prospective observational cohort study JLG Haitsma Mulier, S Rozemeijer, JG Röttgering, AME Spoelstra-de Man, ... PloS one 13 (6), e0197967, 2018 | 83 | 2018 |
Renal resistive index: response to shock and its determinants in critically ill patients S Rozemeijer, JLGH Mulier, JG Röttgering, PWG Elbers, ... Shock 52 (1), 43-51, 2019 | 41 | 2019 |
Symptom networks in glioma patients: understanding the multidimensionality of symptoms and quality of life LD J.G. Röttgering, T. M. C. K. Varkevisser, M. Gorter, V. Belgers, P. C. De ... Journal of Cancer Survivorship, 2023 | 15* | 2023 |
Determining a target SpO2 to maintain PaO2 within a physiological range JG Röttgering, AME de Man, TC Schuurs, EJ Wils, JM Daniels, ... PLoS One 16 (5), e0250740, 2021 | 15 | 2021 |
Toward unraveling the correlates of fatigue in glioma JG Röttgering, V Belgers, PC De Witt Hamer, H Knoop, L Douw, M Klein Neuro-oncology advances 4 (1), vdac169, 2022 | 13 | 2022 |
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis V Belgers, JG Röttgering, L Douw, M Klein, JCF Ket, PM van de Ven, ... Cannabis and Cannabinoid Research, 2022 | 9 | 2022 |
Reducing severe fatigue in patients with diffuse glioma: a study protocol for an RCT on the effect of blended cognitive behavioural therapy JG Röttgering, L Douw, PC de Witt Hamer, MCM Kouwenhoven, ... Trials 23 (1), 568, 2022 | 9 | 2022 |
Tumor location is associated with mood dysfunction in patients with diffuse glioma MNG van Genderen, V Belgers, JM Niers, L Douw, JG Röttgering, ... Nature Mental Health 2 (7), 853-864, 2024 | 2 | 2024 |
Understanding the association between fatigue and neurocognitive functioning in patients with glioma: A cross-sectional multinational study JG Röttgering, JW Taylor, M Brie, T Luks, SL Hervey-Jumper, S Phan, ... Neuro-Oncology Practice 11 (3), 284-295, 2024 | 2 | 2024 |
Letter regarding “Palliative care and end-of-life care in adults with malignant brain tumors” JG Röttgering, M Klein, L Douw Neuro-oncology 25 (3), 612-613, 2023 | 2 | 2023 |
Frequency and burden of potentially treatable symptoms in glioma patients with stable disease JG Röttgering, V Belgers, MCM Kouwenhoven, M Schuur, TJ Postma, ... Heliyon, 2023 | 2 | 2023 |
Changing perspectives on fatigue in glioma: from symptom to system to treatment JG Röttgering | | 2024 |
Self-reported physical functioning and physical fitness in glioma patients: from diagnosis to stable disease MEC Blom, L Douw, M Klein, M Gorter, V Belgers, JG Röttgering, ... OSF, 2024 | | 2024 |
Letter regarding “Acceptability and feasibility of neurocognitive assessments with adults with primary brain cancer and brain metastasis: A systematic review” M Gorter, JG Röttgering, V Belgers, PC De Witt Hamer, L Douw, M Klein Neuro-Oncology Practice 10 (5), 491-492, 2023 | | 2023 |
P01. 03. B COGNITIVE REHABILITATION IN PRIMARY BRAIN CANCER: BASELINE PATIENT CHARACTERISTICS AND NEUROPSYCHOLOGICAL ASSESSMENTS E Smith, C Weyer-Jamora, TL Luks, PM Bracci, M Brie, SL Hervey-Jumper, ... Neuro-Oncology 25 (Supplement_2), ii26-ii26, 2023 | | 2023 |
OS08. 5. A UNDERSTANDING THE ASSOCIATION BETWEEN FATIGUE AND COGNITION IN GLIOMA PATIENTS: AN OBSERVATIONAL MULTINATIONAL STUDY JG Röttgering, JW Taylor, M Brie, T Luks, SL Hervey-Jumper, S Phan, ... Neuro-Oncology 25 (Supplement_2), ii19-ii19, 2023 | | 2023 |
P01. 03. BA quantitative comparison of cognitive performance and patient-reported symptoms in preoperative lower-grade glioma patients from two Dutch Hospitals V Belgers, W van Buijtene, E Butterbrod, JG Röttgering, L Douw, ... Neuro-Oncology 24 (Supplement_2), ii23-ii24, 2022 | | 2022 |
OS09. 4. A Cognitive functioning of patients with diffuse glioma during stable disease MK M Gorter, J G Röttgering, V Belgers, M R van Lingen, P C De Witt Hamer, L ... Neuro-Oncology, 2022 | | 2022 |
P11. 01 Symptom networks in glioma: a novel approach to study multidimensional symptomatology in glioma patients T Varkevisser, JG Röttgering, P de Witt Hamer, MCM Kouwenhoven, ... Neuro-oncology 23 (Supplement_2), ii28-ii29, 2021 | | 2021 |